Australian Luxury Stock News

EVT (ASX:EVT) is back in focus after the company expanded its partnership with CJ 4DPLEX, committing to four additional SCREENX auditoriums across Australia and New Zealand ahead of the upcoming summer blockbuster period. See our latest analysis for EVT. Beyond the SCREENX expansion, EVT’s recent momentum has been positive, with a 10.3% 30 day share price return and a 5.4% 90 day share price return, although the 1 year total shareholder return is down 16.3%. If this premium cinema story has...

Penny stocks attract attention when markets are wrestling with inflation, shifting central bank policies, and uneven consumer demand across regions. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that still show signs of financial health, which may help reduce some of the risks that usually come with early stage businesses. With bond yields moving, commodities reacting to geopolitical events, and retail trends diverging from country to country, this screener...

In June 2026, QBE Insurance Group Limited completed a €500 million fixed-to-floating subordinated note issue and fully redeemed and cancelled its outstanding US$524,124,000 5.875% subordinated notes due 2046, which will be delisted from the Singapore Exchange. This refinancing reshapes QBE’s subordinated debt profile, highlighting active capital structure management and the use of multiple global banks to distribute its new issue. We’ll now look at how this subordinated debt refinancing,...

With inflation signals flickering across regions, central banks cautious on rates, and consumer sentiment mixed, many investors are looking for companies that can grow through different cycles and where insiders have meaningful skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses that combine solid growth potential with management and analyst optimism, which can help align executive incentives with shareholder outcomes. In this article you will...

4DMedical has recently gained US FDA 510(k) clearance for its CT:VQ lung imaging software, launched the CLEAR clinical evidence program for pulmonary embolism, agreed to acquire Austrian AI imaging firm contextflow, and signed a commercial contract with SimonMed Imaging in the US outpatient market. Together, these steps expand 4DMedical’s obtainable US CT:VQ market to about US$3.00 billion while creating an immediate European commercial footprint and new software-as-a-service distribution...

Australian Foundation Investment Company Limited has announced, in June 2026, a fully franked final dividend of A$0.145 per share and a fully franked special dividend of A$0.025 per share for the year ended 30 June 2026, both subject to market conditions and no adverse shocks. The combination of a regular final payout and an additional special dividend highlights management’s focus on distributing income to shareholders through fully franked returns. Next, we will examine how the fully...

China’s central bank has just kept lending rates unchanged, even as recent data points to softer retail sales and industrial output. That choice puts the focus back on income producing stocks that may be better suited to a slower global growth backdrop and more cautious policy signals. This article looks at three defensive dividend stocks from the US, UK, Canada, Australia, and New Zealand that are directly exposed to this news flow, and examines how this decision from the People’s Bank of...

With inflation stories, central bank signals and shifting bond yields pulling markets in different directions, many investors are looking for simpler signposts. One approach is to focus on companies where cash flows look attractive while the stock trades below an estimate of fair value using an SWS DCF valuation. The Undervalued Stocks Based On Cash Flows screener is built exactly for that. It highlights situations where cash flow potential and price may be out of sync. In this article, you...

Nuclear energy stocks are back on many investors’ radar as inflation trends, interest rate expectations, and energy price risks keep long term power security in focus. With central banks weighing future moves and oil markets sensitive to Middle East developments, some investors are looking for sectors tied to reliable, large scale electricity generation. Our Nuclear Energy Stocks screener helps you quickly filter uranium producers, fuel cycle companies, and reactor operators in one place, so...

Earlier today, Stockland announced a partnership with a Morgan Stanley Real Estate Investing vehicle to co-develop three new town centres worth about A$250 million, while reiterating its FY26 funds-from-operations and distribution guidance supported by strong recent sales across key residential segments. A key takeaway is how the sharp increases in masterplanned-community and land-lease net sales appear to underpin confidence in Stockland’s income outlook despite a challenging property...

The Qatar LNG explosion has shaken a key hub in global gas supply, putting a spotlight on how sudden disruptions can ripple through energy markets and into listed stocks. With two LNG trains reportedly affected and a 17% hit to Qatar’s export capacity, investors are asking which oil and gas producers could see changing risk or opportunity as trade flows and pricing adjust. This article looks at 3 stocks from the Global Energy Sector screener that are directly exposed to this news, and...

Rising tensions between India and Pakistan over the Indus Water Treaty are a reminder that geopolitics can quickly reshape risks and opportunities for Global Agricultural Technology (AgTech) stocks. Water security, crop reliability, and power supply are now front and center for investors watching South Asia. This article looks at how that news backdrop could affect select Global AgTech companies, and why some stocks with exposure to these themes may offer interesting risk and reward trade...

As global markets navigate a landscape marked by steady interest rates in the U.S. and rising rates in Japan, small-cap stocks have shown resilience with the Russell 2000 Index gaining 20.06% year-to-date. In this environment, identifying undervalued small-cap companies with recent insider buying can offer potential opportunities for investors looking to capitalize on market dynamics.

Pro Medicus (ASX:PME) drew attention after gaining 3.1% as traders reacted to its upcoming removal from the S&P/ASX 50 index. Heavy volumes were linked to index fund adjustments and recent US contract wins. See our latest analysis for Pro Medicus. The recent spike in activity sits against a mixed longer record for Pro Medicus. The 30 day share price return of 36.49% and 90 day return of 46.11% contrast with a year to date share price decline of 21.56% and a 1 year total shareholder return...

In recent commentary, NEXTDC has been highlighted for ramping up AI-focused data centre expansion and capital investment to support rising cloud and computing infrastructure needs across Australia and Southeast Asia. This renewed attention underscores how AI workloads are turning data centre operators like NEXTDC into essential infrastructure providers, with investors closely assessing execution, funding strength and demand signals. With this backdrop, we’ll explore how NEXTDC’s intensified...

Recent coverage has put Weebit Nano in the spotlight as an ASX-listed semiconductor innovator whose ReRAM memory technology is increasingly linked to AI infrastructure and efficiency needs. This focus on “memflation” – tightening memory supply amid rising AI demand – positions Weebit Nano within a broader debate about how future computing hardware will handle power and performance constraints. Against this backdrop, we’ll explore how Weebit Nano’s role in advanced AI memory solutions shapes...

Bega Cheese recently reported a 21% rise in normalised EBITDA for the first half of FY2026, with its Bulk segment EBITDA increasing very large on the back of improved pricing alignment and product mix, and in response upgraded its normalised EBITDA guidance for FY2026 while reiterating its goal of A$250 million EBITDA by FY2028. This combination of stronger interim earnings and a higher full-year EBITDA outlook highlights how operational changes in both Branded and Bulk segments are feeding...

With economic data sending mixed signals on growth, inflation and consumer demand across regions, many investors are looking for stocks where analysts still see clear earnings expansion and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener is built to surface, by filtering for companies where analysts currently expect strong earnings growth over the next 3 years and which also meet basic financial strength criteria. In this...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

As Australian shares experience slight fluctuations due to geopolitical tensions, investors are keeping a close eye on market developments. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or emerging companies with potential for growth. By focusing on those with strong financial health, these stocks can offer opportunities for stability and upside potential amidst broader market uncertainties.

Dividend Powerhouses can be useful when you want your portfolio to work for you through regular cash income as well as potential capital gains. With central banks watching inflation, energy markets influencing bond yields and consumers showing mixed strength across regions from Canada to Malaysia, many investors are paying closer attention to companies that pay solid, well covered dividends. This Dividend Powerhouses screener focuses on stocks with yields above 5% that are supported by stable...

CSL has recently attracted renewed investor attention after a difficult period marked by earnings downgrades, operational issues across its plasma and vaccine businesses, restructuring moves, and leadership uncertainty. This shift in sentiment has coincided with heavy trading activity, a rotation toward defensive healthcare names, and anticipation around CSL’s upcoming full-year results and dividend announcement. We’ll now explore how this rebound in interest, amid elevated trading volumes...

ASX (ASX:ASX) is back in focus after reaching a settlement with ASIC over misleading statements about its CHESS replacement project, alongside fresh proposals to tighten share issuance rules in takeover and merger deals. See our latest analysis for ASX. ASX shares have been volatile, with a 5.7% 7 day share price return and a 5.9% 90 day share price return. However, the 1 year total shareholder return has declined 22%, highlighting how the latest legal settlement and governance proposals sit...

Transurban Group has completed the M7–M12 Integration Project in Western Sydney, adding an extra lane each way over 26 kilometres and opening the new M7–M12 interchange, which is expected to ease congestion and improve connections to the Western Sydney (Nancy-Bird Walton) Airport. This project, alongside recent financing moves and asset sales, underlines how Transurban is reshaping its toll road portfolio while aiming to support future traffic capacity and regional development. We’ll now...